{"title":"Anomaly Detection in Retinal OCT Images With Deep Learning-Based Knowledge Distillation.","authors":"Guilherme Aresta, Teresa Araújo, Ursula Schmidt-Erfurth, Hrvoje Bogunovic","doi":"10.1167/tvst.14.3.26","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to develop a robust and general purpose artificial intelligence (AI) system that allows the identification of retinal optical coherence tomography (OCT) volumes with pathomorphological manifestations not present in normal eyes in screening programs and large retrospective studies.</p><p><strong>Methods: </strong>An unsupervised anomaly detection deep learning approach for the screening of retinal OCTs with any pathomorphological manifestations via Teacher-Student knowledge distillation is developed. The system is trained with only normal cases without any additional manual labeling. At test time, it scores how anomalous a sample is and produces localized anomaly maps with regions of interest in a B-scan. Fovea-centered OCT scans acquired with Spectralis (Heidelberg Engineering) were considered. A total of 3358 patients were used for development and testing. The detection performance was evaluated in a large data cohort with different pathologies including diabetic macular edema (DME) and the multiple stages of age-related macular degeneration (AMD) and on external public datasets with various disease biomarkers.</p><p><strong>Results: </strong>The volume-wise anomaly detection receiver operating characteristic (ROC) area under the curve (AUC) was 0.94 ± 0.05 in the test set. Pathological B-scan detection on external datasets varied between 0.81 and 0.87 AUC. Qualitatively, the derived anomaly maps pointed toward diagnostically relevant regions. The behavior of the system across the datasets was similar and consistent.</p><p><strong>Conclusions: </strong>Anomaly detection constitutes a valid complement to supervised systems aimed at improving the success of vision preservation and eye care, and is an important step toward more efficient and generalizable screening tools.</p><p><strong>Translational relevance: </strong>Deep learning approaches can enable an automated and objective screening of a wide range of pathological retinal conditions that deviate from normal appearance.</p>","PeriodicalId":23322,"journal":{"name":"Translational Vision Science & Technology","volume":"14 3","pages":"26"},"PeriodicalIF":2.6000,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11954540/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Vision Science & Technology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1167/tvst.14.3.26","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: The purpose of this study was to develop a robust and general purpose artificial intelligence (AI) system that allows the identification of retinal optical coherence tomography (OCT) volumes with pathomorphological manifestations not present in normal eyes in screening programs and large retrospective studies.
Methods: An unsupervised anomaly detection deep learning approach for the screening of retinal OCTs with any pathomorphological manifestations via Teacher-Student knowledge distillation is developed. The system is trained with only normal cases without any additional manual labeling. At test time, it scores how anomalous a sample is and produces localized anomaly maps with regions of interest in a B-scan. Fovea-centered OCT scans acquired with Spectralis (Heidelberg Engineering) were considered. A total of 3358 patients were used for development and testing. The detection performance was evaluated in a large data cohort with different pathologies including diabetic macular edema (DME) and the multiple stages of age-related macular degeneration (AMD) and on external public datasets with various disease biomarkers.
Results: The volume-wise anomaly detection receiver operating characteristic (ROC) area under the curve (AUC) was 0.94 ± 0.05 in the test set. Pathological B-scan detection on external datasets varied between 0.81 and 0.87 AUC. Qualitatively, the derived anomaly maps pointed toward diagnostically relevant regions. The behavior of the system across the datasets was similar and consistent.
Conclusions: Anomaly detection constitutes a valid complement to supervised systems aimed at improving the success of vision preservation and eye care, and is an important step toward more efficient and generalizable screening tools.
Translational relevance: Deep learning approaches can enable an automated and objective screening of a wide range of pathological retinal conditions that deviate from normal appearance.
期刊介绍:
Translational Vision Science & Technology (TVST), an official journal of the Association for Research in Vision and Ophthalmology (ARVO), an international organization whose purpose is to advance research worldwide into understanding the visual system and preventing, treating and curing its disorders, is an online, open access, peer-reviewed journal emphasizing multidisciplinary research that bridges the gap between basic research and clinical care. A highly qualified and diverse group of Associate Editors and Editorial Board Members is led by Editor-in-Chief Marco Zarbin, MD, PhD, FARVO.
The journal covers a broad spectrum of work, including but not limited to:
Applications of stem cell technology for regenerative medicine,
Development of new animal models of human diseases,
Tissue bioengineering,
Chemical engineering to improve virus-based gene delivery,
Nanotechnology for drug delivery,
Design and synthesis of artificial extracellular matrices,
Development of a true microsurgical operating environment,
Refining data analysis algorithms to improve in vivo imaging technology,
Results of Phase 1 clinical trials,
Reverse translational ("bedside to bench") research.
TVST seeks manuscripts from scientists and clinicians with diverse backgrounds ranging from basic chemistry to ophthalmic surgery that will advance or change the way we understand and/or treat vision-threatening diseases. TVST encourages the use of color, multimedia, hyperlinks, program code and other digital enhancements.